Stockpiling at the Onset of the COVID-19 Pandemic: An Empirical Analysis of National Prescription Drug Sales and Prices Last updated on Sep 12, 2023 Go to Project Site Sales difference: drugs related to COVID vs. not related to COVID Stockpiling Drug Shortages Price COVID-19 Healthcare Supply Chains Difference-in-Differences Working Paper Minje Park Related Linking Medication Errors to Supply Chain Disruptions: Evidence from Heparin Shortages Caused by Hurricane Maria Time to Recover Market Share: A New Metric of Supply Chain Resilience Building Resilience Into US Prescription Drug Supply Chains